

Others
DHNP Hydroxyurea Capsule
- Product Type
- Oral Formulations
- Active Ingredient
- Each capsule contains Hydroxyurea 500 mg
- Indications
- Melanoma, chronic myelocytic leukemia resistant to treatment, and recurrent, metastatic, or inoperable carcinoma of the ovary. Hydroxyurea, when used concomitantly with irradiation therapy, is intended for local control of primary squamous cell carcinomas of the head and neck, excluding the lip.


Home